Rally over.. and will be back to 460 levels soon... keep buying at this level.. short term target is 500-520.. *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore. Get live share price chart, key metrics, forecast and ratings of Biocon Ltd - BIOCON on Tickertape View more, .Best time to invest in pharma sector more infoo... telligrram @ttmorg, Rally over.. and will be back to 460 levels soon... keep buying at this level.. short term target is 500-520.. NSE Stock BIOCON - Share Biocon Limited trades in NSE under Biotechnology. Note : Support and Resistance level for the Hosur Road,\n","address2":"Electronics City,\n,","city":"Bengaluru","state":"Karnataka","pincode":"560100","telephone1":"080-28082808","telephone2":"","fax1":"080-28523423","fax2":"","email":"investor.relations@biocon.com","web":"http:\/\/www.biocon.com"},"management":[{"name":"Kiran Mazumdar Shaw","designation":"Executive Chairperson"},{"name":"John Shaw","designation":"Vice Chairman & Non Exe.Dire"},{"name":"Siddharth Mittal","designation":"Managing Director & CEO"},{"name":"Ravi Mazumdar","designation":"Non Executive Director"},{"name":"Mary Harney","designation":"Independent Director"}],"registrars":{"name":"KFIN Technologies Pvt. At the current share price of Rs 471.95 this results in a dividend yield of 0.11%. Currently valued at Good to expensive valuation, Strong Performer: View live BIOCON LTD chart to track its stock's price action. Biocon was founded in 1978 with â¹ 10,000 (US$140) as the initial capital. Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 54864.00 Crore) operating in Pharmaceuticals sector. Read research reports, investor presentations, listen to earnings call and get recommendations from the best minds to maximise your gains. Bullish Momentum - Above Short, Medium and Long Term Moving Averages, Outperformer - Biocon up by 15.07% v/s NIFTY 50 up by 5.22% in last 1 month, Operating Profit Margin (TTM) - Company's Operating Profit Margin growth at 3.35% v/s Industry growth of -0.72%, Price to Book Ratio - Above industry Median, Revenue Growth (TTM) - Company's Revenue growth at 10.44% v/s Industry growth of 10.99%, Profit Growth (TTM) - Company's Profit growth at -26.93% v/s Industry growth of -46.53%, TTM PEG Ratio - Negative PEG TTM Price to Earnings Growth. Biocon financial results, Biocon shareholding, Biocon annual reports, Biocon pledge, Biocon insider trading and compare with peer companies. Click here>. Tell us what we got right and what we didnât? The current market price of Biocon is Rs 461.3. The total volume of shares traded was 4.6 m. Overall, the broader S&P BSE HEALTHCARE Index was up by 0.7%. day, calculated based on price range of the previous trading day. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. Currently valued at Good to expensive valuation. Financial data sourced from CMOTS Internet Technologies Pvt. Biocon Ltd Share/Stock Price in NSE/BSE Online. Nanakramguda,Seri, Your feedback matters! Share Price & News. Get Biocon Live NSE/BSE Share Price and Stock Price today along with detailed News, Financial Results, Stock Charts, Returns, Research Reports and more. Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Positional and Intraday Trading Calls basis Noiseless Chart, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, (OI Hosur Road, An analysis of stocks based on price performance, financials, the Piotroski score and shareholding. Advanced charts with more than 100 technical indicators, tools and studies will give you the edge, making it easier to negotiate the market and its swings.